Multilayered defense in HLA-B51-associated HIV viral control

Journal of Immunology

Volumn 187, Issue 2, 2011, Pages 684-691

  Zhang, YongHong ^a,b   Peng, YanChun ^b   Yan, HuiPing ^a   Xu, Keyi ^c   Saito, Masumichi ^d   Wu, Hao ^a   Chen, XinYue ^a   Ranasinghe, Srinika ^b   Kuse, Nozomi ^d   Powell, Tim ^b   Zhao, Yan ^a   Li, WeiHua ^a   Zhang, Xin ^a   Feng, Xia ^a   Li, Ning ^a   Leligdowicz, Aleksandra ^b   Xu, XiaoNing ^b   John, Mina ^e   Takiguchi, Masafumi ^d   McMichael, Andrew ^b   Rowland Jones, Sarah ^b   Dong, Tao ^b   more..

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d MURDOCH UNIVERSITY   (Australia)

^e KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; HLA B51 ANTIGEN; NEF PROTEIN; POL PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD DONOR; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; GENE MUTATION; HLA TYPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY; VIRUS LOAD;

CLONE CELLS; COHORT STUDIES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HEK293 CELLS; HIV-1; HLA-B ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; MUTATION; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 79960488721     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100316     Document Type: Article

References (27)

1. Le Clerc, S., C. Coulonges, O. Delaneau, D. Van Manen, J. T. Herbeck, S. Limou, P. An, J. J. Martinson, J. L. Spadoni, A. Therwath, et al. 2011. Screening low-frequency SNPS from genome wide association study reveals a new risk allele for progression to AIDS. J. Acquir. Immune Defic. Syndr. 56: 279-284.
2. International HIV Controllers Study, F. Pereyra, X. Jia, P. J. McLaren, A. Telenti, P. I. de Bakker, B. D. Walker, S. Ripke, C. J. Brumme, S. L. Pulit, et al. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330: 1551-1557.
3. + T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13: 46-53.
4. Martin, M. P., X. Gao, J. H. Lee, G. W. Nelson, R. Detels, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, M. Wilson, S. J. O'Brien, and M. Carrington. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31: 429-434.
5. Martin, M. P., Y. Qi, X. Gao, E. Yamada, J. N. Martin, F. Pereyra, S. Colombo, E. E. Brown, W. L. Shupert, J. Phair, et al. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39: 733-740.
6. Phillips, R. E., S. L. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. Bangham, C. R. Rizza, and A. J. McMichael. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354: 453-459.
7. Kawashima, Y., K. Pfafferott, J. Frater, P. Matthews, R. Payne, M. Addo, H. Gatanaga, M. Fujiwara, A. Hachiya, H. Koizumi, et al. 2009. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458: 641-645.
8. Rowland-Jones, S. 2004. AIDS pathogenesis: what have two decades of research taught us? Bull. Mem. Acad. R. Med. Belg. 159: 171-175.
9. Goulder, P. J., R. E. Phillips, R. A. Colbert, S. McAdam, G. Ogg, M. A. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, et al. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3: 212-217.
10. Goulder, P. J., and D. I. Watkins. 2004. HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol. 4: 630-640.
11. McMichael, A. J., P. Borrow, G. D. Tomaras, N. Goonetilleke, and B. F. Haynes. 2010. The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol. 10: 11-23.
12. Gao, X., A. Bashirova, A. K. Iversen, J. Phair, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, M. Altfeld, S. J. O'Brien, and M. Carrington. 2005. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat. Med. 11: 1290-1292.
13. Martinez-Picado, J., J. G. Prado, E. E. Fry, K. Pfafferott, A. Leslie, S. Chetty, C. Thobakgale, I. Honeyborne, H. Crawford, P. Matthews, et al. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80: 3617-3623.
14. Kelleher, A. D., C. Long, E. C. Holmes, R. L. Allen, J. Wilson, C. Conlon, C. Workman, S. Shaunak, K. Olson, P. Goulder, et al. 2001. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 193: 375-386.
15. + T-cell escape mutations and covarying HLA-independent polymorphisms. J. Virol. 85: 1384-1390.
16. Carrington, M., and S. J. O'Brien. 2003. The influence of HLA genotype on AIDS. Annu. Rev. Med. 54: 535-551.
17. Dong, T., Y. Zhang, K. Y. Xu, H. Yan, I. James, Y. Peng, M. E. Blais, S. Gaudieri, X. Chen, W. Lun, et al. 2011. Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China. Blood DOI:10.1182/blood-2010-06-291963.
18. Dong, T., G. Stewart-Jones, N. Chen, P. Easterbrook, X. Xu, L. Papagno, V. Appay, M. Weekes, C. Conlon, C. Spina, et al. 2004. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J. Exp. Med. 200: 1547-1557.
19. Lee, L. Y., L. A. Ha do, C. Simmons, M. D. de Jong, N. V. Chau, R. Schumacher, Y. C. Peng, A. J. McMichael, J. J. Farrar, G. L. Smith, et al. 2008. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J. Clin. Invest. 118: 3478-3490.
20. Dong, T., E. Moran, N. Vinh Chau, C. Simmons, K. Luhn, Y. Peng, B. Wills, N. Phuong Dung, L. Thi Thu Thao, T. T. Hien, et al. 2007. High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection. PLoS One 2: e1192.
21. Tomiyama, H., N. Yamada, H. Komatsu, K. Hirayama, and M. Takiguchi. 2000. A single CTL clone can recognize a naturally processed HIV-1 epitope presented by two different HLA class I molecules. Eur. J. Immunol. 30: 2521-2530.
22. Tomiyama, H., M. Fujiwara, S. Oka, and M. Takiguchi. 2005. Cutting edge: epitope-dependent effect of nef-mediated HLA class I down-regulation on ability of HIV-1-specific CTLs to suppress HIV-1 replication. J. Immunol. 174: 36-40. (Pubitemid 40007389)
23. Brumme, Z. L., C. J. Brumme, J. Carlson, H. Streeck, M. John, Q. Eichbaum, B. L. Block, B. Baker, C. Kadie, M. Markowitz, et al. 2008. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J. Virol. 82: 9216-9227.
24. Altfeld, M., E. T. Kalife, Y. Qi, H. Streeck, M. Lichterfeld, M. N. Johnston, N. Burgett, M. E. Swartz, A. Yang, G. Alter, et al. 2006. HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8+ T cell response against HIV-1. PLoS Med. 3: e403.
25. Matano, T., M. Kobayashi, H. Igarashi, A. Takeda, H. Nakamura, M. Kano, C. Sugimoto, K. Mori, A. Iida, T. Hirata, et al. 2004. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. J. Exp. Med. 199: 1709-1718.
26. Kawada, M., T. Tsukamoto, H. Yamamoto, N. Iwamoto, K. Kurihara, A. Takeda, C. Moriya, H. Takeuchi, H. Akari, and T. Matano. 2008. Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial. J. Virol. 82: 10199-10206.
27. Allen, T. M., X. G. Yu, E. T. Kalife, L. L. Reyor, M. Lichterfeld, M. John, M. Cheng, R. L. Allgaier, S. Mui, N. Frahm, et al. 2005. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J. Virol. 79: 12952-12960. (Pubitemid 41433214)